logo
Plus   Neg
Share
Email

Abbott's FreeStyle Libre System Reduces Diabetic Ketoacidosis-Related Hospitalization Rates

Abbott (ABT) announced results from multiple new real-world studies that demonstrate how use of the FreeStyle Libre system, the world-leading5 continuous glucose monitoring technology, can lead to significant clinical benefits among people living with type 1 and type 2 diabetes.

The findings showed that using the FreeStyle Libre technology is associated with substantial reductions in hospitalizations from diabetic ketoacidosis, a serious condition that can lead to diabetic coma or even death.

The results also showed a decrease in rates of acute diabetes events (ADE) and all-cause hospitalizations as well as lowered and sustained hemoglobin A1c (HbA1C) levels.

In the study, researchers assessed nationwide reimbursement claims data in France of 74,158 people living with diabetes, including 33,203 people with type 1 diabetes and 40,955 people with type 2 diabetes.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT